Series D - Kythera Biopharmaceuticals

Series D - Kythera Biopharmaceuticals

Investment Firm

Overview

Kythera Biopharmaceuticals discovers, develops and commercializes novel prescription products for the aesthetic medicine market.

Announced Date

Sep 19, 2011

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

Latham & Watkins

Latham & Watkins

No designation

Participant Investors

8

Investor Name
Participant InvestorLatham & Watkins
Participant InvestorInvus
Participant InvestorProspect Venture Partners
Participant InvestorVersant Ventures
Participant InvestorARCH Venture Partners

Round Details and Background

Kythera Biopharmaceuticals raised $37400000 on 2011-09-19 in Series D

Kythera Biopharmaceuticals discovers, develops and commercializes novel prescription products for the aesthetic medicine market.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 19, 2011
Series D - Kythera Biopharmaceuticals
8-37.4M
Sep 16, 2005
Seed Round - Kythera Biopharmaceuticals
1-1.0M
Jul 24, 2006
Series B - Kythera Biopharmaceuticals
6-30.0M
May 19, 2008
Series C - Kythera Biopharmaceuticals
8-30.0M

Recent Activity

There is no recent news or activity for this profile.